Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2022-A02815-38 | Other Identifier | id-RCB |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Acute respiratory distress (ARD) is a frequent reason for seeking care in emergency medicine and represents an important cause of morbidity and mortality. Among the various etiologies, Acute Cardiogenic Pulmonary Edema (C APE) currently represents one of the main causes of ARD, particularly in the elderly, with a prevalence of 43% and an estimated mortality of 21%. According to the recommendations issued in 2021 by the European Society of Cardiology (ESC), the treatment of cardiogenic APE is currently based on a triptych combining:
At present, no additional examination is recommended to determine the patient's volume status. However, it has been shown more recently that some patients who do not have absolute hypervolaemia could develop acute renal complications during treatment for C APE. In addition, systematic treatment with loop diuretics in patients without absolute hypervolaemia could be harmful by inducing post-treatment hypovolaemia.
At the present time, there are no data from the literature having been interested in the possible association existing between the state of blood volume of the patient on admission and the occurrence of renal complications in the aftermath of the treatment. initial. The prevalence of renal complications was nevertheless evaluated at 9% in this category of patients. The estimated prevalence of this complication and its particular seriousness, particularly in the case of chronic acute kidney injury, as well as its cost to society, justify carrying out a study aimed at evaluating the prevalence of venous congestion in the acute phase and of its possible association with the occurrence of renal complications in the course of this.
Among the various methods for assessing blood volume status, there is a growing literature regarding the use of clinical ultrasound in emergency medicine (ECMU). More recently, an ultrasound score called "VExUS score" (Venous Excess Ultrasound Score) has been developed. This offers the possibility of evaluating and classifying in 4 grades of increasing severity, simply and quickly, the state of venous congestion of patients. This score is based on the presence or absence of venous Doppler ultrasound abnormalities assessed at the level of the inferior vena cava, at the level of the supra-hepatic veins, of the portal and renal venous flow. This score, adapted to the practice of ECMU and making it possible to distinguish patients with or without venous congestion criteria, could provide arguments to guide diuretic treatment by offering personalized care. This evaluation would ultimately make it possible to offer diuretic treatment only in the event of signs suggestive of absolute hypervolaemia and thus avoid the occurrence of complications related to inappropriate therapy.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| " VExUS score " (Venous Excess Ultrasound Score) | Other | " VExUS score " (Venous Excess Ultrasound Score) |
| Measure | Description | Time Frame |
|---|---|---|
| Estimate the prevalence of the different grades of venous congestion assessed by the VExUS score in ultrasound | VExUS score in ultrasound score 0 to 3 / Higher score means worse outcome | within 12 hours of admission |
| Measure | Description | Time Frame |
|---|---|---|
| Evaluate the association between the different ultrasound grades of venous congestion described by the ultrasound VExUS score and the occurrence of renal complications during hospitalization defined by the MAKE-Discharge | Major Adverse Kidney Events (MAKE), composite criterion : - Criterion 1 : De novo acute renal failure (ARI) or worsening of pre-existing chronic renal failure (CRI), defined according to the Kidney Disease: Improving Global Outcomes (KDIGO) reference classification |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patient with cardiogenic Acute Pulmonary Edema
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Lucie AUZANNEAU | Contact | 0262359949 | +262 | lucie.auzanneau@chu-reunion.fr |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CHU de la Réunion | Recruiting | Saint-Denis | 97400 | France |
Not provided
Not provided
Not provided
Not provided
| 7 days, 30 days, 180 days |
| Evaluate the association between the different ultrasound grades of venous congestion described by the ultrasound VExUS score and the occurrence of renal complications during hospitalization defined by the MAKE-Discharge | Major Adverse Kidney Events (MAKE), composite criterion :
| 7 days, 30 days, 180 days |
| Evaluate the association between the different ultrasound grades of venous congestion described by the ultrasound VExUS score and the occurrence of renal complications during hospitalization defined by the MAKE-Discharge | Major Adverse Kidney Events (MAKE), composite criterion :
| 7 days, 30 days, 180 days |
| Assess the association between the grade of the VExUS ultrasound score on admission and the total and daily dose of furosemide administered to the patient | dose of furosemide | 7 days |
| Evaluate the kinetics of evolution of the VExUS ultrasound score performed at the patient's bedside in comparison with the values found on admission | VExUS score in ultrasound score 0 to 3 / Higher score means worse outcome | within 12 hours of admission , day 3 day 7 |
| Evaluate the association between the presence of venous congestion (VExUS score ≥ 1) or not and vital and functional status : Gerontological autonomy iso-resource groups | Gerontological autonomy iso-resource groups (score AGGIR) Value 1 to 6 / Higher score mean better outcome | day 7, day 30, day 180 |
| Evaluate the association between the presence of venous congestion (VExUS score ≥ 1) or not and vital and functional status : Activities of daily living | Activities of daily living (score ADL) Value 1 to 6 / Higher score mean better outcome | day 7, day 30, day 180 |
| Evaluate the association between the presence of venous congestion (VExUS score ≥ 1) or not and vital and functional status : Barthel Index | Barthel Index Value 0 to 100 / Higher score mean better outcome | day 7, day 30, day 180 |